TMO EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
TMO's ev/ebitda is higher than 95% of the last 10 years.
EV/EBITDA History
TMO EV/EBITDA by year
Yearly range of TMO’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 15.4 to 28.1, averaging 20.3.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 18.0 | 21.3 | 26.6 | 26.6 |
| 2025 | 15.4 | 19.1 | 22.9 | 21.7 |
| 2024 | 19.1 | 21.5 | 23.4 | 19.4 |
| 2023 | 17.8 | 21.2 | 23.9 | 21.3 |
| 2022 | 18.5 | 20.8 | 24.1 | 20.7 |
| 2021 | 15.6 | 18.6 | 24.9 | 24.9 |
| 2020 | 16.9 | 23.2 | 28.1 | 19.6 |
| 2019 | 16.6 | 19.5 | 21.4 | 20.9 |
| 2018 | 16.9 | 19.7 | 21.9 | 17.4 |
| 2017 | 16.4 | 18.9 | 21.3 | 20.4 |
| 2016 | 17.1 | 17.6 | 18.5 | 17.2 |
Get notified when TMO EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is TMO EV/EBITDA High or Low Right Now?
Thermo Fisher Scientific Inc.'s EV/EBITDA is currently 26.6, which is near historic high relative to its 10-year historical range. The 10-year median EV/EBITDA for TMO is approximately 20.2. See all TMO valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.